# Directs the commissioner of health to conduct a sickle cell disparity study

**Bill ID:** S8921
**Session:** 2024
**Sponsor:** Kevin S. Parker
**Status:** In Senate Committee
**PDF:** [S8921 PDF](https://legislation.nysenate.gov/pdf/bills/2024/S8921)

## Summary

Directs the commissioner of health to conduct a sickle cell disparity study.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  8921
 
  I N  S E N A T E
 
  March 28, 2024
  ___________
 
 Introduced  by  Sen.  PARKER -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health
 
 AN ACT in relation to directing the commissioner of health to conduct  a
  sickle  cell  disparity  study;  and  providing for the repeal of such
  provisions upon expiration thereof
 
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. 1. The commissioner of health is authorized and directed to
 conduct a sickle cell disparity study.
  2.  Such  study  shall  determine whether there is a disparity between
 treatment accessibility and affordability for persons with  sickle  cell
 disease  and  persons  with  other  chronic illnesses, including but not
 limited to lupus, cancer, diabetes, and heart disease.
  3. Not later than eighteen months after the  effective  date  of  this
 act,  the  commissioner shall post the results of such study on the open
 health data section of the department of health's website.
  ยง 2. This act shall take effect immediately and shall  expire  and  be
 deemed repealed two years after such effective date.
 
 
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD14371-01-4